ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2026
Coronary Flow in Hypertrophic Obstructive Cardiomyopathy-Immediate Effects of Alcohol Septal Ablation.
Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertrophic cardiomyopathy is associated with alterations in coronary microvascular function which have variable pathophysiologic mechanisms, and variable reversibility acutely and chronically following alcohol septal ablation (ASA).
aimsThe aim of this study was to examine immediate changes in absolute coronary blood flow before and after ASA using continuous thermodilution.
methodsConsecutive eligible patients without obstructive coronary artery disease undergoing ASA in a single center were enrolled in the study. Absolute coronary blood flow (Q) was measured using continuous thermodilution technique before and immediately after ASA and was used to calculate coronary flow reserve (CFR) and resistance (R).
resultsTwenty-three patients, aged 57.9 ± 12.6 years, 47.8% female, underwent ASA. Left ventricular outflow tract gradient decreased from a median of 101 mmHg [IQR 77-133] to a median of 19 mmHg [16-36 mmHg] (p < 0.01). Comparing the state before and after ASA, no changes were observed in average resting (0.126 ± 0.064 vs. 0.129 ± 0.081 L/min) or hyperemic (0.264 ± 0.136 vs. 0.248 ± 0.116 L/min) coronary blood flow, or between resting (868 ± 564 vs. 929 ± 618 mmHg/[L/min]) or hyperemic (351 ± 172 vs. 345 ± 126 mmHg/[L/min]) resistance (p > 0.05 for all). The majority of patients n = 16 (69.6%) had an abnormal CFR (≤ 2.5) prior to ASA. Mean CFR was 2.31 ± 1.02 before and 2.35 ± 1.04 after ASA (p = 0.808 for difference). Thirteen patients experienced CFR improvement by 10%, and they had significantly lower hyperemic Q (0.219 ± 0.087 vs. 0.336 ± 0.171 L/min, p = 0.041) and CFR (1.86 ± 0.76 vs. 2.85 ± 1.19, p = 0.041) before ASA, compared to those who didn't.
conclusionsPatients with obstructive hypertrophic cardiomyopathy are a heterogeneous population with variable immediate microvascular response to ASA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.